Am J Physiol Cell Physiol Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Cell Physiol 291: C76-C82, 2006. First published February 8, 2006; doi:10.1152/ajpcell.00508.2005
0363-6143/06 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
291/1/C76    most recent
00508.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Web of Science (6)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Oh, Y. S.
Right arrow Articles by Turner, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Oh, Y. S.
Right arrow Articles by Turner, R. J.

RECEPTORS AND SIGNAL TRANSDUCTION

Effect of {gamma}-secretase inhibitors on muscarinic receptor-mediated calcium signaling in human salivary epithelial cells

Young S. Oh and R. James Turner

Membrane Biology Section, Gene Therapy and Therapeutics Branch, National Institute of Dental and Craniofacial Resarch, Bethesda, Maryland

Submitted 12 October 2005 ; accepted in final form 2 February 2006

Altered intracellular Ca2+ signaling has been observed in cells derived from Alzheimer’s disease patients, and a possible link between {gamma}-secretase activity and the content of intracellular Ca2+ stores has been suggested. To test this hypothesis we studied the effects of several {gamma}-secretase inhibitors on muscarinic receptor-mediated intracellular calcium release in the human salivary gland cell line HSG. Although several inhibitors in the peptide aldehyde class partially blocked carbachol-induced Ca2+ transients, these effects did not appear to be due to {gamma}-secretase inhibition, and overall we found no evidence that inhibition of {gamma}-secretase activity had any significant effect on agonist-induced intracellular calcium release in HSG cells. In complementary experiments with presenilin-null cells we found that the reconstitution of {gamma}-secretase activity by transfection with wild-type presenilin 1 likewise had no significant effect on thapsigargin-induced Ca2+ release. In a test of the specific hypothesis that the level of APP intracellular domain (AICD), the intracellular fragment of the beta-amyloid precursor protein (APP) resulting from {gamma}-secretase cleavage, can modulate the Ca2+ content of the endoplasmic reticulum, we were unable to demonstrate any effect of APP small interfering RNA on the magnitude of carbachol-induced intracellular calcium release in HSG cells. Together our data cast considerable doubt on the hypothesis that there is a direct link between {gamma}-secretase activity and the content of intracellular Ca2+ stores.

presenilin; carbachol; inositol 1,4,5-trisphosphate; Alzheimer’s disease



Address for reprint requests and other correspondence: R. J. Turner, National Institute of Dental and Craniofacial Research, Bldg 10, Rm. 1A01, GTTB, Bethesda, MD 20892 (e-mail: rjturner{at}mail.nih.gov)







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2006 by the American Physiological Society.